Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia but does not add to prognostic utility of the revised IPSS

著录项

• 期刊名称 other
• 作者

  Amer M Zeidan; Ju-Whei Lee; Thomas Prebet; Peter Greenberg; Zhuoxin Sun; Mark Juckett; Mitchell R Smith; Elisabeth Paietta; Janice Gabrilove; Harry P Erba; Martin S. Tallman; Steven D. Gore;

  展开▼
• 作者单位

  展开▼
• 年(卷),期 -1(167),1
• 年度 -1
• 页码 62–68
• 总页数 15
• 原文格式 PDF
• 正文语种
• 中图分类
• 关键词

  Myelodysplastic syndromes (MDS) azacitidine Revised International Prognostic Scoring System (IPSS-R) French Prognostic Scoring System (FPSS) prognostic models;

  机译：骨髓增生异常综合症（MDS）;阿扎胞苷;经修订的国际预后评分系统（IPSS-R）;法国预后评分系统（FPSS）;预后模型;